Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

Introduction Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation ex...

Full description

Bibliographic Details
Main Authors: Jon Dorling, Souvik Mitra, Ruben Alvaro, Jaideep Kanungo, Christine Drolet, Nadya Ben Fadel, Prakesh Shah, Xiang Y Ye, Amish Jain, Faiza Khurshid, Joseph Y. Ting, Miroslav Stavel, Ayman Abou Mehrem, Amuchou Soraisham, Bonny Jasani, Deepak Louis, Anie Lapointe, Abbas Hyderi, Kumar Kumaran, Jaya Bodani, Dany Weisz, Mohammed Adie, Alyssa Morin, Soume Bhattacharya, Rody Canning, Tara Hatfield, Courtney E Gardner
Format: Article
Language:English
Published: BMJ Publishing Group 2021-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/5/e050682.full

Internet

https://bmjopen.bmj.com/content/11/5/e050682.full

Similar Items